The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression

Depression is a global mental health concern, and personalized treatment approaches are needed to optimize its management. This study aimed to investigate the influence of the CYP2D6 and CYP1A2 gene polymorphisms on the efficacy of duloxetine in reducing depressive and anxiety symptoms. A sample of...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciaszek, Julian, Pawłowski, Tomasz, Hadryś, Tomasz, Machowska, Marta, Wiela-Hojeńska, Anna, Misiak, Błażej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487921/
https://www.ncbi.nlm.nih.gov/pubmed/37686266
http://dx.doi.org/10.3390/ijms241713459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487921/
https://www.ncbi.nlm.nih.gov/pubmed/37686266
http://dx.doi.org/10.3390/ijms241713459

Ejemplares similares